The ongoing COVID-19 pandemic caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has resulted in more than 28,000,000 infections and 900,000 …

The spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
mediates host cell entry by binding to angiotensin-converting enzyme 2 (ACE2) and is …

SARS-CoV-2 is a health threat with dire socioeconomical consequences. As the crucial
mediator of infection, the viral glycosylated spike protein (S) has attracted the most attention …

The trimeric spike (S) glycoprotein, which protrudes from the SARS-CoV-2 viral envelope,
binds to human ACE2, initiated by at least one protomer's receptor binding domain (RBD) …

Here we have generated 3D structures of glycoforms of the spike (S) glycoprotein from
SARS-CoV-2, based on reported 3D structures and glycomics data for the protein produced …

SARS-CoV-2 infection is controlled by the opening of the spike protein receptor binding
domain (RBD), which transitions from a glycan-shielded 'down'to an exposed 'up'state to …

This technical study describes all-atom modeling and simulation of a fully glycosylated full-
length SARS-CoV-2 spike (S) protein in a viral membrane. First, starting from PDB: 6VSB …

The ongoing COVID-19 pandemic caused by the new coronavirus, SARS-CoV-2, calls for
urgent developments of vaccines and antiviral drugs. The spike protein of SARS-CoV-2 (S …

The glycan shield of the beta-coronavirus (β-CoV) Spike (S) glycoprotein provides protection
from host immune responses, acting as a steric block to potentially neutralizing antibody …

The emergence of the betacoronavirus, SARS-CoV-2 that causes COVID-19, represents a
significant threat to global human health. Vaccine development is focused on the principal …